Laws: Cases and Codes : U.S. Code : Title 21 : Section 802


   


U.S. Code as of: 01/19/04
Section 802. Definitions

      As used in this subchapter:
      (1) The term "addict" means any individual who habitually uses
    any narcotic drug so as to endanger the public morals, health,
    safety, or welfare, or who is so far addicted to the use of
    narcotic drugs as to have lost the power of self-control with
    reference to his addiction.
      (2) The term "administer" refers to the direct application of a
    controlled substance to the body of a patient or research subject
    by - 
        (A) a practitioner (or, in his presence, by his authorized
      agent), or
        (B) the patient or research subject at the direction and in the
      presence of the practitioner,

    whether such application be by injection, inhalation, ingestion, or
    any other means.
      (3) The term "agent" means an authorized person who acts on
    behalf of or at the direction of a manufacturer, distributor, or
    dispenser; except that such term does not include a common or
    contract carrier, public warehouseman, or employee of the carrier
    or warehouseman, when acting in the usual and lawful course of the
    carrier's or warehouseman's business.
      (4) The term "Drug Enforcement Administration" means the Drug
    Enforcement Administration in the Department of Justice.
      (5) The term "control" means to add a drug or other substance, or
    immediate precursor, to a schedule under part B of this subchapter,
    whether by transfer from another schedule or otherwise.
      (6) The term "controlled substance" means a drug or other
    substance, or immediate precursor, included in schedule I, II, III,
    IV, or V of part B of this subchapter. The term does not include
    distilled spirits, wine, malt beverages, or tobacco, as those terms
    are defined or used in subtitle E of the Internal Revenue Code of
    1986.
      (7) The term "counterfeit substance" means a controlled substance
    which, or the container or labeling of which, without
    authorization, bears the trademark, trade name, or other
    identifying mark, imprint, number, or device, or any likeness
    thereof, of a manufacturer, distributor, or dispenser other than
    the person or persons who in fact manufactured, distributed, or
    dispensed such substance and which thereby falsely purports or is
    represented to be the product of, or to have been distributed by,
    such other manufacturer, distributor, or dispenser.
      (8) The terms "deliver" or "delivery" mean the actual,
    constructive, or attempted transfer of a controlled substance or a
    listed chemical, whether or not there exists an agency
    relationship.
      (9) The term "depressant or stimulant substance" means - 
        (A) a drug which contains any quantity of barbituric acid or
      any of the salts of barbituric acid; or
        (B) a drug which contains any quantity of (i) amphetamine or
      any of its optical isomers; (ii) any salt of amphetamine or any
      salt of an optical isomer of amphetamine; or (iii) any substance
      which the Attorney General, after investigation, has found to be,
      and by regulation designated as, habit forming because of its
      stimulant effect on the central nervous system; or
        (C) lysergic acid diethylamide; or
        (D) any drug which contains any quantity of a substance which
      the Attorney General, after investigation, has found to have, and
      by regulation designated as having, a potential for abuse because
      of its depressant or stimulant effect on the central nervous
      system or its hallucinogenic effect.

      (10) The term "dispense" means to deliver a controlled substance
    to an ultimate user or research subject by, or pursuant to the
    lawful order of, a practitioner, including the prescribing and
    administering of a controlled substance and the packaging, labeling
    or compounding necessary to prepare the substance for such
    delivery. The term "dispenser" means a practitioner who so delivers
    a controlled substance to an ultimate user or research subject.
      (11) The term "distribute" means to deliver (other than by
    administering or dispensing) a controlled substance or a listed
    chemical. The term "distributor" means a person who so delivers a
    controlled substance or a listed chemical.
      (12) The term "drug" has the meaning given that term by section
    321(g)(1) of this title.
      (13) The term "felony" means any Federal or State offense
    classified by applicable Federal or State law as a felony.
      (14) The term "isomer" means the optical isomer, except as used
    in schedule I(c) and schedule II(a)(4). As used in schedule I(c),
    the term "isomer" means any optical, positional, or geometric
    isomer. As used in schedule II(a)(4), the term "isomer" means any
    optical or geometric isomer.
      (15) The term "manufacture" means the production, preparation,
    propagation, compounding, or processing of a drug or other
    substance, either directly or indirectly or by extraction from
    substances of natural origin, or independently by means of chemical
    synthesis or by a combination of extraction and chemical synthesis,
    and includes any packaging or repackaging of such substance or
    labeling or relabeling of its container; except that such term does
    not include the preparation, compounding, packaging, or labeling of
    a drug or other substance in conformity with applicable State or
    local law by a practitioner as an incident to his administration or
    dispensing of such drug or substance in the course of his
    professional practice. The term "manufacturer" means a person who
    manufactures a drug or other substance.
      (16) The term "marihuana" means all parts of the plant Cannabis
    sativa L., whether growing or not; the seeds thereof; the resin
    extracted from any part of such plant; and every compound,
    manufacture, salt, derivative, mixture, or preparation of such
    plant, its seeds or resin. Such term does not include the mature
    stalks of such plant, fiber produced from such stalks, oil or cake
    made from the seeds of such plant, any other compound, manufacture,
    salt, derivative, mixture, or preparation of such mature stalks
    (except the resin extracted therefrom), fiber, oil, or cake, or the
    sterilized seed of such plant which is incapable of germination.
      (17) The term "narcotic drug" means any of the following whether
    produced directly or indirectly by extraction from substances of
    vegetable origin, or independently by means of chemical synthesis,
    or by a combination of extraction and chemical synthesis:
        (A) Opium, opiates, derivatives of opium and opiates, including
      their isomers, esters, ethers, salts, and salts of isomers,
      esters, and ethers, whenever the existence of such isomers,
      esters, ethers, and salts is possible within the specific
      chemical designation. Such term does not include the isoquinoline
      alkaloids of opium.
        (B) Poppy straw and concentrate of poppy straw.
        (C) Coca leaves, except coca leaves and extracts of coca leaves
      from which cocaine, ecgonine, and derivatives of ecgonine or
      their salts have been removed.
        (D) Cocaine, its salts, optical and geometric isomers, and
      salts of isomers.
        (E) Ecgonine, its derivatives, their salts, isomers, and salts
      of isomers.
        (F) Any compound, mixture, or preparation which contains any
      quantity of any of the substances referred to in subparagraphs
      (A) through (E).

      (18) The term "opiate" means any drug or other substance having
    an addiction-forming or addiction-sustaining liability similar to
    morphine or being capable of conversion into a drug having such
    addiction-forming or addiction-sustaining liability.
      (19) The term "opium poppy" means the plant of the species
    Papaver somniferum L., except the seed thereof.
      (20) The term "poppy straw" means all parts, except the seeds, of
    the opium poppy, after mowing.
      (21) The term "practitioner" means a physician, dentist,
    veterinarian, scientific investigator, pharmacy, hospital, or other
    person licensed, registered, or otherwise permitted, by the United
    States or the jurisdiction in which he practices or does research,
    to distribute, dispense, conduct research with respect to,
    administer, or use in teaching or chemical analysis, a controlled
    substance in the course of professional practice or research.
      (22) The term "production" includes the manufacture, planting,
    cultivation, growing, or harvesting of a controlled substance.
      (23) The term "immediate precursor" means a substance - 
        (A) which the Attorney General has found to be and by
      regulation designated as being the principal compound used, or
      produced primarily for use, in the manufacture of a controlled
      substance;
        (B) which is an immediate chemical intermediary used or likely
      to be used in the manufacture of such controlled substance; and
        (C) the control of which is necessary to prevent, curtail, or
      limit the manufacture of such controlled substance.

      (24) The term "Secretary", unless the context otherwise
    indicates, means the Secretary of Health and Human Services.
      (25) The term "serious bodily injury" means bodily injury which
    involves - 
        (A) a substantial risk of death;
        (B) protracted and obvious disfigurement; or
        (C) protracted loss or impairment of the function of a bodily
      member, organ, or mental faculty.

      (26) The term "State" means a State of the United States, the
    District of Columbia, and any commonwealth, territory, or
    possession of the United States.
      (27) The term "ultimate user" means a person who has lawfully
    obtained, and who possesses, a controlled substance for his own use
    or for the use of a member of his household or for an animal owned
    by him or by a member of his household.
      (28) The term "United States", when used in a geographic sense,
    means all places and waters, continental or insular, subject to the
    jurisdiction of the United States.
      (29) The term "maintenance treatment" means the dispensing, for a
    period in excess of twenty-one days, of a narcotic drug in the
    treatment of an individual for dependence upon heroin or other
    morphine-like drugs.
      (30) The term "detoxification treatment" means the dispensing,
    for a period not in excess of one hundred and eighty days, of a
    narcotic drug in decreasing doses to an individual in order to
    alleviate adverse physiological or psychological effects incident
    to withdrawal from the continuous or sustained use of a narcotic
    drug and as a method of bringing the individual to a narcotic
    drug-free state within such period.
      (31) The term "Convention on Psychotropic Substances" means the
    Convention on Psychotropic Substances signed at Vienna, Austria, on
    February 21, 1971; and the term "Single Convention on Narcotic
    Drugs" means the Single Convention on Narcotic Drugs signed at New
    York, New York, on March 30, 1961.
      (32)(A) Except as provided in subparagraph (C), the term
    "controlled substance analogue" means a substance - 
        (i) the chemical structure of which is substantially similar to
      the chemical structure of a controlled substance in schedule I or
      II;
        (ii) which has a stimulant, depressant, or hallucinogenic
      effect on the central nervous system that is substantially
      similar to or greater than the stimulant, depressant, or
      hallucinogenic effect on the central nervous system of a
      controlled substance in schedule I or II; or
        (iii) with respect to a particular person, which such person
      represents or intends to have a stimulant, depressant, or
      hallucinogenic effect on the central nervous system that is
      substantially similar to or greater than the stimulant,
      depressant, or hallucinogenic effect on the central nervous
      system of a controlled substance in schedule I or II.

      (B) The designation of gamma butyrolactone or any other chemical
    as a listed chemical pursuant to paragraph (34) or (35) does not
    preclude a finding pursuant to subparagraph (A) of this paragraph
    that the chemical is a controlled substance analogue.
      (C) Such term does not include - 
        (i) a controlled substance;
        (ii) any substance for which there is an approved new drug
      application;
        (iii) with respect to a particular person any substance, if an
      exemption is in effect for investigational use, for that person,
      under section 355 of this title to the extent conduct with
      respect to such substance is pursuant to such exemption; or
        (iv) any substance to the extent not intended for human
      consumption before such an exemption takes effect with respect to
      that substance.

      (33) The term "listed chemical" means any list I chemical or any
    list II chemical.
      (34) The term "list I chemical" means a chemical specified by
    regulation of the Attorney General as a chemical that is used in
    manufacturing a controlled substance in violation of this
    subchapter and is important to the manufacture of the controlled
    substances, and such term includes (until otherwise specified by
    regulation of the Attorney General, as considered appropriate by
    the Attorney General or upon petition to the Attorney General by
    any person) the following:
        (A) Anthranilic acid, its esters, and its salts.
        (B) Benzyl cyanide.
        (C) Ephedrine, its salts, optical isomers, and salts of optical
      isomers.
        (D) Ergonovine and its salts.
        (E) Ergotamine and its salts.
        (F) N-Acetylanthranilic acid, its esters, and its salts.
        (G) Norpseudoephedrine, its salts, optical isomers, and salts
      of optical isomers.
        (H) Phenylacetic acid, its esters, and its salts.
        (I) Phenylpropanolamine, its salts, optical isomers, and salts
      of optical isomers.
        (J) Piperidine and its salts.
        (K) Pseudoephedrine, its salts, optical isomers, and salts of
      optical isomers.
        (L) 3,4-Methylenedioxyphenyl-2-propanone.
        (M) Methylamine.
        (N) Ethylamine.
        (O) Propionic anhydride.
        (P) Isosafrole.
        (Q) Safrole.
        (R) Piperonal.
        (S) N-Methylephedrine.
        (T) N-methylpseudoephedrine.
        (U) Hydriodic acid.
        (V) Benzaldehyde.
        (W) Nitroethane.
        (X) Gamma butyrolactone.
        (Y) Any salt, optical isomer, or salt of an optical isomer of
      the chemicals listed in subparagraphs (M) through (U) of this
      paragraph.

      (35) The term "list II chemical" means a chemical (other than a
    list I chemical) specified by regulation of the Attorney General as
    a chemical that is used in manufacturing a controlled substance in
    violation of this subchapter, and such term includes (until
    otherwise specified by regulation of the Attorney General, as
    considered appropriate by the Attorney General or upon petition to
    the Attorney General by any person) the following chemicals:
        (A) Acetic anhydride.
        (B) Acetone.
        (C) Benzyl chloride.
        (D) Ethyl ether.
        (E) Repealed. Pub. L. 101-647, title XXIII, Sec. 2301(b), Nov.
      29, 1990, 104 Stat. 4858.
        (F) Potassium permanganate.
        (G) 2-Butanone (or Methyl Ethyl Ketone).
        (H) Toluene.
        (I) Iodine.
        (J) Hydrochloric gas.

      (36) The term "regular customer" means, with respect to a
    regulated person, a customer with whom the regulated person has an
    established business relationship that is reported to the Attorney
    General.
      (37) The term "regular importer" means, with respect to a listed
    chemical, a person that has an established record as an importer of
    that listed chemical that is reported to the Attorney General.
      (38) The term "regulated person" means a person who manufactures,
    distributes, imports, or exports a listed chemical, a tableting
    machine, or an encapsulating machine or who acts as a broker or
    trader for an international transaction involving a listed
    chemical, a tableting machine, or an encapsulating machine.
      (39) The term "regulated transaction" means - 
        (A) a distribution, receipt, sale, importation, or exportation
      of, or an international transaction involving shipment of, a
      listed chemical, or if the Attorney General establishes a
      threshold amount for a specific listed chemical, a threshold
      amount, including a cumulative threshold amount for multiple
      transactions (as determined by the Attorney General, in
      consultation with the chemical industry and taking into
      consideration the quantities normally used for lawful purposes),
      of a listed chemical, except that such term does not include - 
          (i) a domestic lawful distribution in the usual course of
        business between agents or employees of a single regulated
        person;
          (ii) a delivery of a listed chemical to or by a common or
        contract carrier for carriage in the lawful and usual course of
        the business of the common or contract carrier, or to or by a
        warehouseman for storage in the lawful and usual course of the
        business of the warehouseman, except that if the carriage or
        storage is in connection with the distribution, importation, or
        exportation of a listed chemical to a third person, this clause
        does not relieve a distributor, importer, or exporter from
        compliance with section 830 of this title;
          (iii) any category of transaction or any category of
        transaction for a specific listed chemical or chemicals
        specified by regulation of the Attorney General as excluded
        from this definition as unnecessary for enforcement of this
        subchapter or subchapter II of this chapter;
          (iv) any transaction in a listed chemical that is contained
        in a drug that may be marketed or distributed lawfully in the
        United States under the Federal Food, Drug, and Cosmetic Act
        (21 U.S.C. 301 et seq.) unless - 
            (I)(aa) the drug contains ephedrine or its salts, optical
          isomers, or salts of optical isomers, pseudoephedrine or its
          salts, optical isomers, or salts of optical isomers, or
          phenylpropanolamine or its salts, optical isomers, or salts
          of optical isomers unless otherwise provided by regulation of
          the Attorney General issued pursuant to section 814(e) of
          this title, except that any sale of ordinary over-the-counter
          pseudoephedrine or phenylpropanolamine products by retail
          distributors shall not be a regulated transaction (except as
          provided in section 401(d) of the Comprehensive
          Methamphetamine Control Act of 1996); or
            (bb) the Attorney General has determined under section 814
          of this title that the drug or group of drugs is being
          diverted to obtain the listed chemical for use in the illicit
          production of a controlled substance; and
            (II) the quantity of ephedrine, pseudoephedrine,
          phenylpropanolamine, or other listed chemical contained in
          the drug included in the transaction or multiple transactions
          equals or exceeds the threshold established for that chemical
          by the Attorney General, except that the threshold for any
          sale of products containing pseudoephedrine or
          phenylpropanolamine products by retail distributors or by
          distributors required to submit reports by section 830(b)(3)
          of this title shall be 9 grams of pseudoephedrine or 9 grams
          of phenylpropanolamine in a single transaction and sold in
          package sizes of not more than 3 grams of pseudoephedrine
          base or 3 grams of phenylpropanolamine base; or

          (v) any transaction in a chemical mixture which the Attorney
        General has by regulation designated as exempt from the
        application of this subchapter and subchapter II of this
        chapter based on a finding that the mixture is formulated in
        such a way that it cannot be easily used in the illicit
        production of a controlled substance and that the listed
        chemical or chemicals contained in the mixture cannot be
        readily recovered; and

        (B) a distribution, importation, or exportation of a tableting
      machine or encapsulating machine.

      (40) The term "chemical mixture" means a combination of two or
    more chemical substances, at least one of which is not a list I
    chemical or a list II chemical, except that such term does not
    include any combination of a list I chemical or a list II chemical
    with another chemical that is present solely as an impurity.
      (41)(A) The term "anabolic steroid" means any drug or hormonal
    substance, chemically and pharmacologically related to testosterone
    (other than estrogens, progestins, and corticosteroids) that
    promotes muscle growth, and includes - 
        (i) boldenone,
        (ii) chlorotestosterone,
        (iii) clostebol,
        (iv) dehydrochlormethyltestosterone,
        (v) dihydrotestosterone,
        (vi) drostanolone,
        (vii) ethylestrenol,
        (viii) fluoxymesterone,
        (ix) formebulone,
        (x) mesterolone,
        (xi) methandienone,
        (xii) methandranone,
        (xiii) methandriol,
        (xiv) methandrostenolone,
        (xv) methenolone,
        (xvi) methyltestosterone,
        (xvii) mibolerone,
        (xviii) nandrolone,
        (xix) norethandrolone,
        (xx) oxandrolone,
        (xxi) oxymesterone,
        (xxii) oxymetholone,
        (xxiii) stanolone,
        (xxiv) stanozolol,
        (xxv) testolactone,
        (xxvi) testosterone,
        (xxvii) trenbolone, and
        (xxviii) any salt, ester, or isomer of a drug or substance
      described or listed in this paragraph, if that salt, ester, or
      isomer promotes muscle growth.

      (B)(i) Except as provided in clause (ii), such term does not
    include an anabolic steroid which is expressly intended for
    administration through implants to cattle or other nonhuman species
    and which has been approved by the Secretary of Health and Human
    Services for such administration.
      (ii) If any person prescribes, dispenses, or distributes such
    steroid for human use, such person shall be considered to have
    prescribed, dispensed, or distributed an anabolic steroid within
    the meaning of subparagraph (A).
      (42) The term "international transaction" means a transaction
    involving the shipment of a listed chemical across an international
    border (other than a United States border) in which a broker or
    trader located in the United States participates.
      (43) The terms "broker" and "trader" mean a person that assists
    in arranging an international transaction in a listed chemical by -
    
        (A) negotiating contracts;
        (B) serving as an agent or intermediary; or
        (C) bringing together a buyer and seller, a buyer and
      transporter, or a seller and transporter.

      (44) The term "felony drug offense" means an offense that is
    punishable by imprisonment for more than one year under any law of
    the United States or of a State or foreign country that prohibits
    or restricts conduct relating to narcotic drugs, marihuana, or
    depressant or stimulant substances.
      (45) The term "ordinary over-the-counter pseudoephedrine or
    phenylpropanolamine product" means any product containing
    pseudoephedrine or phenylpropanolamine that is - 
        (A) regulated pursuant to this subchapter; and
        (B)(i) except for liquids, sold in package sizes of not more
      than 3.0 grams of pseudoephedrine base or 3.0 grams of
      phenylpropanolamine base, and that is packaged in blister packs,
      each blister containing not more than two dosage units, or where
      the use of blister packs is technically infeasible, that is
      packaged in unit dose packets or pouches; and
        (ii) for liquids, sold in package sizes of not more than 3.0
      grams of pseudoephedrine base or 3.0 grams of phenylpropanolamine
      base.

      (46)(A) The term "retail distributor" means a grocery store,
    general merchandise store, drug store, or other entity or person
    whose activities as a distributor relating to pseudoephedrine or
    phenylpropanolamine products are limited almost exclusively to
    sales for personal use, both in number of sales and volume of
    sales, either directly to walk-in customers or in face-to-face
    transactions by direct sales.
      (B) For purposes of this paragraph, sale for personal use means
    the sale of below-threshold quantities in a single transaction to
    an individual for legitimate medical use.
      (C) For purposes of this paragraph, entities are defined by
    reference to the Standard Industrial Classification (SIC) code, as
    follows:
        (i) A grocery store is an entity within SIC code 5411.
        (ii) A general merchandise store is an entity within SIC codes
      5300 through 5399 and 5499.
        (iii) A drug store is an entity within SIC code 5912.



Previous [Notes] Next

Related Resources

Health Law Guide

Department of Health and Human Services Directory

Department of Justice Directory

Agriculture Discussion


Ads by FindLaw